(Q34708125)

4 August 2017

1 reference

title

Drug-induced skin, nail and hair disorders (English)

1 reference

4 August 2017

author name string

Laurence Valeyrie-Allanore

series ordinal

1 reference

4 August 2017

Bruno Sassolas

series ordinal

1 reference

4 August 2017

Jean-Claude Roujeau

series ordinal

1 reference

4 August 2017

language of work or name

1 reference

1 January 2007

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

page(s)

1011-1030

1 reference

Delayed Drug Hypersensitivity Reactions

4 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002018-200730110-00003

Apparently normal phenytoin metabolism in a patient with phenytoin-induced rash and lymphadenopathy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002018-200730110-00003

Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis Are Severity Variants of the Same Disease which Differs from Erythema Multiforme

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002018-200730110-00003

Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study

21 January 2018

1 reference

12 December 2020

Drug-induced hair loss and hair growth. Incidence, management and avoidance

1 reference

12 December 2020

Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry

1 reference

12 December 2020

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer

1 reference

12 December 2020

Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis

1 reference

12 December 2020

[Drug hypersensitivity syndrome: DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms)]

1 reference

12 December 2020

T-cell involvement in drug-induced acute generalized exanthematous pustulosis

1 reference

12 December 2020

Anticoagulant-related skin reactions

1 reference

12 December 2020

Clinical aspects of streptococcal and staphylococcal toxinic diseases

1 reference

12 December 2020

The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema

1 reference

12 December 2020

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

1 reference

12 December 2020

Cutaneous drug reactions: pathogenesis and clinical classification

1 reference

12 December 2020

Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis

1 reference

12 December 2020

Idiopathic familial onychomadesis

1 reference

12 December 2020

Fixed eruptions: causative drugs and challenge tests

1 reference

12 December 2020

Medical genetics: a marker for Stevens-Johnson syndrome

1 reference

12 December 2020

[Acute generalized exanthematic pustuloses (four cases) (author's transl)]

1 reference

12 December 2020

[Misleading or rare cutaneous drug reactions]

1 reference

12 December 2020

Anticonvulsant hypersensitivity syndrome: incidence, prevention and management

1 reference

12 December 2020

Onycholysis as a complication of systemic chemotherapy: report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature

1 reference

12 December 2020

Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern

1 reference

12 December 2020

Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme

1 reference

12 December 2020

Cutaneous side-effects of kinase inhibitors and blocking antibodies

1 reference

12 December 2020

Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors

1 reference

12 December 2020

Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants

1 reference

12 December 2020

Cutaneous manifestations of antiretroviral therapy.

1 reference

12 December 2020

Idiosyncratic drug reactions: the reactive metabolite syndromes

1 reference

12 December 2020

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

1 reference

12 December 2020

Paronychia associated with antiretroviral therapy

1 reference

12 December 2020

Clinical heterogeneity of drug hypersensitivity

1 reference

12 December 2020

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

1 reference

12 December 2020

Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients

1 reference

12 December 2020

Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction

1 reference

12 December 2020

Nail, skin, and scleral pigmentation induced by minocycline

1 reference

12 December 2020

Complications of therapy in cancer patients: Case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer

1 reference

12 December 2020

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

1 reference

12 December 2020

Drug-induced urticarias

1 reference

12 December 2020

Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus

1 reference

12 December 2020

Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms.

1 reference

12 December 2020

Clinical practice. Antibiotic allergy

1 reference

12 December 2020

Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis

1 reference

12 December 2020

Drug-Associated Deaths of Medical Inpatients

1 reference

12 December 2020

SCORTEN: a severity-of-illness score for toxic epidermal necrolysis

1 reference

12 December 2020

Drug-induced pemphigus

1 reference

12 December 2020

Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression

1 reference

12 December 2020

Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome

1 reference

12 December 2020

Paronychia induced by cetuximab, an antiepidermal growth factor receptor antibody

1 reference

12 December 2020

Pemphigus and Bullous Pemphigoid due to Drugs

1 reference

12 December 2020

Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program

1 reference

12 December 2020

Drug hypersensitivity reactions and human immunodeficiency virus disease

1 reference

12 December 2020

Drugs associated with bullous pemphigoid. A case-control study

1 reference

12 December 2020

Nail pigmentation associated with zidovudine: a review and report of a case

1 reference

12 December 2020

Drug-induced lupus erythematosus.

1 reference

12 December 2020

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

1 reference

12 December 2020

Paronychia and pyogenic granuloma-like lesions with isotretinoin

1 reference

12 December 2020

Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities

1 reference

12 December 2020

Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey

1 reference

12 December 2020

Cutaneous vasculitis: a review

1 reference

12 December 2020

Onychomadesis and onycholysis associated with capecitabine

1 reference

12 December 2020

Drug-induced nail disorders: incidence, management and prognosis

1 reference

12 December 2020

Drug-associated alopecia

1 reference

12 December 2020

Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management

1 reference

12 December 2020

Clofazimine induced nail changes

1 reference

12 December 2020

Mucocutaneous reactions to chemotherapy

1 reference

12 December 2020

Severe adverse cutaneous reactions to drugs

1 reference

12 December 2020

Acute generalized exanthematous pustulosis. Analysis of 63 cases

1 reference

12 December 2020

10.2165/00002018-200730110-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1047378816

0 references

1 reference